ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,575.90
-1.39%
S&P ASX All Technology
2,970.40
-1.25%
Brent Oil
88.165
0.00%
US Dollar vs AUD
1.53139
0.00%
Bitcoin
63,237.89
-0.79%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. T2 Biosystems Inc (TTOO)

  7. T2 Biosystems Inc (TTOO) News

TTOO T2 Biosystems Inc

2.81
0.07 (2.55%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
T2 Biosystems Inc TTOO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.07 2.55% 2.81 09:58:35
Open Price Low Price High Price Close Price Previous Close
2.76 2.7001 2.9353 2.84 2.74
more quote information »

Recent News

Date Time Source Heading
24/4/202423:00GLOBET2 Biosystems to Report First Quarter 2024 Financial Results..
12/4/202406:05GLOBET2 Biosystems Shareholders Vote for CRG Debt Conversion into..
29/3/202400:00GLOBET2 Biosystems Announces Extension of Multi-Year Capital..
20/3/202422:30GLOBET2 Biosystems Unveils T2Lyme Launch Plans and Provides..
20/3/202400:00GLOBET2 Biosystems to Host Investor Call on March 20, 2024 to..
19/3/202400:00GLOBET2 Biosystems Announces New Publication Highlighting the..
13/3/202400:00GLOBET2 Biosystems Receives Extension to Comply with Nasdaq..
05/3/202408:34EDGAR2Form DEF 14A - Other definitive proxy statements
28/2/202408:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202408:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202408:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202408:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202408:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202408:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202408:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202409:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202409:00EDGAR2Form 8-K - Current report
16/2/202408:49EDGAR2Form PRE 14A - Other preliminary proxy statements
16/2/202408:47EDGAR2Form 8-K - Current report
16/2/202408:06GLOBET2 Biosystems Announces Preliminary Fourth Quarter and Full..
16/2/202408:04GLOBET2 Biosystems Announces Agreement with CRG for the..
16/2/202408:02GLOBET2 Biosystems Announces Commercial Expansion Through..
14/2/202412:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202401:00GLOBET2 Biosystems Receives FDA 510(k) Clearance for the Expanded..
08/2/202408:05GLOBET2 Biosystems to Report Fourth Quarter and Full Year 2023..
19/1/202401:00GLOBET2 Biosystems Announces Participation in NIH-funded..
06/1/202408:00EDGAR2Form 8-K - Current report
04/1/202408:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202401:00GLOBET2 Biosystems Announces FDA 510(k) Submission to Expand Use..
29/11/202308:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202308:00EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
25/11/202308:30EDGAR2Form 8-K/A - Current report: [Amend]
04/11/202300:00GLOBET2 Biosystems to Participate in the Canaccord Genuity..
02/11/202300:08EDGAR2Form 8-K - Current report
02/11/202300:00GLOBET2 Biosystems Regains Compliance with Nasdaq Listing..
26/10/202300:02EDGAR2Form 8-K - Current report
25/10/202307:05GLOBET2 Biosystems Highlights New Clinical Data Presented at..
24/10/202300:00EDGAR2Form 8-K - Current report
24/10/202300:00GLOBET2 Biosystems Announces Amendment and Extension of CRG Term..
21/10/202307:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/10/202307:31EDGAR2Form 8-K - Current report
13/10/202307:32EDGAR2Form 8-K - Current report
13/10/202307:05GLOBET2 Biosystems Announces Preliminary Third Quarter 2023..
13/10/202307:02GLOBET2 Biosystems Announces FDA 510(k) Submission to Expand the..
13/10/202307:01EDGAR2Form 8-K - Current report
13/10/202300:00GLOBET2 Biosystems Announces Reverse Stock Split Effective Today
12/10/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

NASDAQ
TTOO
T2 Biosystems
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved